Health, health inequality, and cost impacts of annual increases in tobacco tax: multistate life table modeling in New Zealand
Authors: Blakely T et al.
Summary: These researchers estimated the impacts of ongoing tobacco tax increases (10% annually from 2011
to 2031) compared with no tax increases from 2011 in New Zealand, where there are large ethnic inequalities in
smoking-related and noncommunicable disease burden. Sixteen tobacco-related diseases were modelled in parallel
using national data by sex, age, and ethnicity, to estimate undiscounted quality-adjusted life-years (QALYs) gained
and net health system costs over the remaining life of the 2011 population (n=4.4 million). Compared to the 2011
cohort exposed to no tax increases, 260,000 QALYs were gained among those exposed to annual tobacco tax
increases from 2011 to 2031. Cost savings associated with this intervention amounted to US$2,550 million over
the remainder of the 2011 population’s life. QALY gains and cost savings took 50 years to peak. The QALY gains
per capita associated with annual tobacco tax increases were 3.7-fold higher for Māori compared with non-Māori
because of higher rates of smoking and price sensitivity among Māori. Health inequalities measured by differences in
mortality rates among Māori and non-Māori aged 45+ years were projected to be 2.31% lower in 2041 with ongoing
tax rises, compared with no tax rises. Percentage reductions in inequalities in 2041 were maximal for 45–64-yearold
women (3.01%).
Reference: Reference: PLoS Med. 2015;12(7):e1001856
Abstract
30-year trends in stroke rates and outcome in Auckland, New Zealand (1981-2012): a multi-ethnic population-based series of studies
Authors: Feigin VL et al.
Summary: In this study, 5400 new stroke patients aged ≥15 years were registered in four 12-month recruitment
phases (1981–1982, 1991–1992, 2002–2003 and 2011–2012) in Auckland, New Zealand. Ethnicity was selfidentified
into 4 major groups: 79% New Zealand/European, 6% Māori, 8% Pacific people, and 7% Asian or Other
origin. From 1981 to 2012, overall stroke incidence and 1-year mortality decreased by 23% and 62%, respectively.
Whilst stroke incidence and mortality declined across all groups in NZ from 1991, Māori and Pacific groups had
the slowest rate of decline and continue to experience stroke at a significantly younger age (mean ages 60 and
62 years, respectively) compared with New Zealand/Europeans (mean age 75 years). There was also a decline
in 28-day stroke case fatality (overall by 14%) across all ethnic groups from 1981 to 2012. However, there were
significant increases in the frequencies of pre-morbid hypertension, myocardial infarction, and diabetes mellitus, but
a reduction in frequency of current smoking among stroke patients.
Reference: Reference: PLoS One. 2015;10(8):e0134609
Abstract